Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
GlobeNewswire
· SELARSDI is approved for both adult and pediatric indications and is the second biosimilar approved under the strategic..
